Tower Research Capital (TRC)’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
Tower Research Capital (TRC)'s TWST Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Twist Bioscience (TWST) stake by 14% in Q3 2026, selling an estimated $46.8K and leaving 2,271 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #1778.
Tower Research Capital (TRC) first reported a position in TWST in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.67M in Q1 2021. 435 funds tracked by Wall St. Rank hold TWST as of Q3 2026.
- Tower Research Capital (TRC) held 2,271 shares of Twist Bioscience worth $439K as of Q3 2026.
- Tower Research Capital (TRC) sold 379 Twist Bioscience shares in Q3 2026, an estimated $46.8K.
- Twist Bioscience made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #1778 holding.
- Tower Research Capital (TRC) first reported a position in Twist Bioscience in Q4 2018 and has held it in 30 quarters since.
- Tower Research Capital (TRC)'s Twist Bioscience position peaked at $3.67M in Q1 2021.
- 435 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.